Suneet Varma, Global Oncology & U.S. President at Pfizer, tells SurvivorNet that the company aims to continue making progress related to improving cancer screening rates by leveraging technology to ...

Increasing Screening Through Patient Education Efforts to improve cancer screening through awareness campaigns are having an impact, as a study published in JAMA indicates a “58% reduction in breast ...

Pfizer president says the pharmaceutical company are taking steps to improve access to care for diverse populations.

PARP Inhibitors For Advanced Prostate Cancer PARP inhibitors are a newer class of oral therapies for advanced prostate cancer that target faulty DNA repair mechanisms. This class of drugs is ...

For men facing advanced prostate cancer, doctors may order a series of tests to assess how far the cancer has spread and what treatment approach to recommend. When a doctor suspects more advanced ...

Members of the LGBTQ+ community face elevated cancer risks, according to a new study by the American Cancer Society in the realm of increased smoking, alcohol consumption, and obesity.

Former “Good Morning America” host Charlie Gibson, 81, was a fixture on TV sets for millions of Americans during the ‘80s and ‘90s; towards the end of his broadcast career, he became a cancer advocate ...

Jane Fonda Celebrates Remission Jane Fonda, 84, says she's in remission after being diagnosed with non-Hodgkin's lymphoma earlier this year. Her announcement comes about three months after she ...

Follicular lymphoma is a slow-growing blood cancer that often needs no immediate treatment. Learn how watchful waiting, new antibody therapies, and CAR T-cell treatment offer real hope for long-term ...

BeiGene placing added emphasis on strengthening education pipelines for patients and physicians and prioritizing mental health resources.

Joanna Kerns was diagnosed with breast cancer the same week her co-star Robin Thicke passed away after a heart attack in December 2016.

Hormone therapy, also known as androgen deprivation therapy (ADT), is the foundation of treatment for advanced prostate cancer and works by reducing or blocking testosterone, which fuels cancer growth ...